| Gilad Bar-Lev |
Gilad Bar-Lev is Chief Executive Officer & Director at Therapix Biosciences Ltd.
He received an undergraduate degree from St. Francis College. |
| Oz Adler |
Oz Adler is Chief Financial Officer of Therapix Biosciences Ltd.
In his past career Oz Adler occupied the position of Member of Ernst & Young Global Ltd.
He received an undergraduate degree from The College of Management Academic Studies. |
| Ascher Shmulewitz |
Ascher Shmulewitz is an Israeli entrepreneur who founded 9 companies, which include: San Francisco Science, Innovopro Ltd. and V-Wave Ltd. Presently, Dr. Shmulewitz holds the position of Chairman for Therapix Biosciences Ltd. Dr. Shmulewitz is also on the board of 7 other companies.
In her past career Dr. Shmulewitz was Chairman at My Size, Inc. and Head-Pharmaceutical Issues & Directions at Metamorefix Ltd.
Dr. Shmulewitz received a doctorate from Tel-Aviv University and a graduate degree from Technion-Israel Institute of Technology. |
| Adi Zuloff-Shani |
Presently, Adi Zuloff-Shani holds the position of Chief Technology Officer at Therapix Biosciences Ltd.
She previously held the position of Vice President-Development at Macrocure Ltd.
She received a doctorate and an undergraduate degree from Bar-Ilan University. |
| Stephen M. Siems |
Stephen M. Siems is a businessperson who has been at the head of 5 different companies. He is on the board of Ceregene, Inc. and Therapix Biosciences Ltd.
In his past career Mr. Siems occupied the position of Chief Executive Officer at Diffusion Pharmaceuticals, Inc. and Chief Executive Officer & Director at RestorGenex Corp. (a subsidiary of Diffusion Pharmaceuticals, Inc.), Vice Chairman, President & Chief Executive Officer at ANI Pharmaceuticals, Inc., Chairman, President & Chief Executive Officer for Gynex Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Unimed Pharmaceuticals LLC, Principal at G.D. Searle & Co., Inc. and Director & Senior Vice President at Savient Pharmaceuticals, Inc.
Stephen M. Siems received an MBA from New York University and an undergraduate degree from Brooklyn College. |
| Amit E. Berger |
Amit E. Berger holds the position of Chairman & Chief Executive Officer of Dolphin 1 Investments Ltd. He is also on the board of 15 other companies.
He previously was Chairman at Prisma Investment House Ltd., Chairman at Dash Investments Ltd. and Chairman at Enter Holdings 1 Ltd.
Amit E. Berger received an undergraduate degree from Tel-Aviv University. |
| Yafit Stark |
Yafit Stark holds the position of Chairman for Omnix Medical Ltd. Dr. Stark is also on the board of Therapix Biosciences Ltd.
She previously was Chief Clinical Officer at Teva Pharmaceutical Industries Ltd.
She received a doctorate from Weizmann Institute of Science and a doctorate from Tel-Aviv University. |
| Zohar Heiblum |
Founder of Tefen (I.L) Israel Ltd., Zohar Heiblum is Managing Partner at Momentum Management. Mr. Heiblum is also on the board of Therapix Biosciences Ltd., Daniron-Consulting & Investments Ltd. and Roth Z. Industries Ltd. and Manager-Research & Development Plan at MATIMOP.
In the past Zohar Heiblum occupied the position of Co-Chairman of Intelicanna Ltd., Chief Executive Officer for Alvarion Ltd., Chief Operating & Financial Officer of Celtro Communication (2012) Ltd. and Chief Operations & Financial Officer at Celtro, Inc. (a subsidiary of Celtro Communication (2012) Ltd.), Chairman of OREX Computed Radiography Ltd. and General Manager for MobileAccess Networks, Inc.
He received an undergraduate degree and an MBA from Tel-Aviv University. |
| Todd Violette |
Todd Violette is on the board of Therapix Biosciences Ltd. |
